Journey Medical (DERM) Expected to Post Earnings on Tuesday
Market Beat·- Journey Medical is expected to release its Q2 2026 earnings results on Tuesday, August 11th, with analysts forecasting a loss of $0.01 per share and revenue of $18.3590 million. - The commercial dermatology company recently reported previous Q2 financial metrics alongside steady institutional investment shifts and varied analyst ratings. - Shares of DERM traded at $6.54 with a market capitalization of $180.05 million ahead of the upcoming earnings announcement.